Articles On Telix Pharmaceuticals (ASX:TLX)

The ASX was down 0.55% on Wednesday AUD drops below US64c RBA tells the ASX to improve its governance   The stock market continues to be volatile as local shares wiped yesterday’s gains to close 0.55% lower on Wednesday. The Tech sector l...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the day deep in the red. At the time of writing, the benchmark index is down 0.75% to 6,447 points. Four ASX shares that are falling more than most today are list...

ShareCafeASX marginally lower: Aus shares down 0.3% at noon By Lauren Hayes   The ASX gave up modest gains in this morning’s trade to dip into the red at lunchtime trading. At noon, the S&P/ASX 200 is 0.32 per cent or 20.70 points lower...

Telix Pharmaceuticals (TLX) has withdrawn its application to market its Illuccix product in EuropeThis comes after the Danish Medicines Agency requested additional data that Telix said it couldn’t deliver within the prescribed review timefr...

Highlights The Australian shares opened higher on Wednesday. The ASX 200 index opened 14.40 points, or 0.22% higher at 6,510.60. The benchmark has shed 2.83% in past five days. The Australian shares opened higher on We...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a tumble on Wednesday. In morning trade, the therapeutic radiopharmaceuticals company’s shares are down 12% to $4.74. Why is the Telix share price sinking? Investors have been...

MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approv...

MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose in Australia of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of...

ShareCafeLunch Report: 27 September, 2022 by Lauren Hayes   The ASX is trading higher this morning despite the Dow Jones index entering a bear market overnight, and the British pound having fallen to a record low against the greenback as in...

MELBOURNE, Australia, Sept. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and GenesisCare, the largest provider of integrated cancer care in Australia, today announce that a first patient has been e...

Telix Pharma releases positive study results for TLX101 Imugene doses first patient in Phase 1 clinical trial Final IPAX-1 study data has confirmed the safety and tolerability profile for TLX101, according to Telix Pharma (ASX:TLX). The s...

MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L-[ 131I] iodo-phenylalanine, or 131I-IPA...

While there are many successful companies on the ASX that solely serve Australian consumers, there are huge markets to be conquered beyond the seas that girt this land. Expanding internationally is difficult to execute but the end result o...

ShareCafeEvening Report: 20 September, 2022 by Paul Sanger   Australian shares posted solid gains, after Wall Street recovered from its two-day losing streak as investors wait to see how aggressively the US Federal Reserve will lift interes...

Highlights The ASX 200 benchmark index closed up today, gaining 1.29% to end at 6,806.40 points. Over the last five days, the index has lost 2.90% and has shed off 6.10% over the last 52 weeks. Materials was the best performing sector...

Aussie shares caught an up-lift from a general improvement in market mood as investors prepare for a jumbo US rate hike and embrace the possibility of smaller increases in Australia. The S&P/ASX 200 bounced 86.5 points or 1.29 per ce...

Australian home and business owners are now paying back more than two more percentage points in interest than they were just four months ago. The Reserve Bank of Australia is deliberately trying to slow the economy to bring inflation under...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

The S&P/ASX 200 Index (ASX: XJO) broke a two-session losing streak on Wednesday as energy shares bolstered the market. The index closed 0.52% higher at 6,998.10 points. The S&P/ASX 200 Energy Index (ASX: XEJ) led the way on Wednesd...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

MELBOURNE, Australia and NANTES, France, Aug. 24, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Nantes-based ATONCO S.A.S. (‘ATONCO’) today announced that the final patient has been dosed in a Phase...

Australian nuclear medicine company Telix Pharmaceuticals has reported a 726 per cent rise in revenue for the six months to the end of June.

The S&P/ASX 200 Index (ASX: XJO) had a rough start to the week, but plenty of shares managed to buck its downwards trend. The Index closed Monday’s session 0.95% lower at 7,046.90 points. The S&P/ASX 200 Consumer Discretionary In...

Telix Pharmaceuticals' prostate cancer imaging product Illucix is quickly conquering the USA, but management at the firm has (much) higher ambitions. ASX Code: ((TLX)) Market cap: $2.02bn Shares on issue: 312,916,341 Chief executive officer...

A busy week of corporate earnings faces a rocky start after Wall Street’s four-week winning run ended as traders grew more cautious about the outlook for interest rates. ASX futures declined 29 points or 0.41 per cent. The S&P/ASX 20...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. ASX health sector modestly up...

ShareCafeEvening Report: 18 August, 2022 by Paul Sanger   At the closing bell, the S&P/ASX 200 was 0.21 per cent or 14.90 points lower at 7112.80. The Dow Jones futures are pointing to a fall of 58 points. The S&P 500 futures are po...

The share market suffered its first setback in four sessions following weak US leads and as “messy” jobs data muddied the outlook for interest rates. The S&P/ASX 200 declined 15 points or 0.21 per cent from yesterday’s ten-week closi...

The ASX 200 finished lower today Xero dragged down Tech sector  Australia’s jobless rate is at 3.4% lowest in almost half a century   The ASX 200 index fell for the first time this week, down by 0.30%, as Tech stocks dragged the bourse lo...

The share market fell for the first time in four sessions following weak leads from Wall Street, declines in key commodities and earnings misses from Origin Energy and Transurban. The S&P/ASX 200 declined 22 points or 0.31 per cent t...

Respiri gives update on US market Screening results from 19 of Emyria’s MDMA compounds have been returned Telix reports strong half-year results Respiratory disease specialist, Respiri (ASX:RSH), surged 14% this morning after updating the...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price plunged in early trade on Thursday after the company revealed its results for the half-year ending 30 June. Shares in the ASX biotech company are currently trading down 4.1% at $6.96 aft...

Aussie stocks were poised to open lower following a volatile session in the US as investors assessed mixed earnings from retailers and the likelihood of another jumbo interest rate hike next month. The Dow’s five-session win streak ended...

Recent cap raising suggests biotechs may finally be making a comeback Mesblast annnounced a US$45m cap raise last week Today, Paradigm, Opthea, and Proteomics also announced fund raises Over the past year, the biotech sector has been caug...

ShareCafeLunch Report: 12 August, 2022 by Paul Sanger   At noon, the S&P/ASX 200 is 0.42 per cent or 29.50 points lower at 7041.50. The SPI futures are pointing to a fall of 32 points. Best and worst performers The best-performing secto...

JPMorgan’s equities desk is seeking buyers about a 3 per cent stake in ASX-listed Telix Pharmaceuticals on Thursday evening. 

Telix (ASX:TLX) has announced that it has been jointly awarded a $4.8 million Australian Research Council grant to establish a new Industrial Transformation Research Program Hub as part of a consortium of applicants led by The Unive...

MELBOURNE, Australia, Aug. 8, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has been jointly awarded a $4.8 million Australian Research Council (ARC) grant to establish a new Ind...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price finished the session on Friday up 0.52% to $7.79. Over the past month, the ASX healthcare share has risen in value by an extraordinary 50.1%. Contributing to this gain was the investor...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Morgans takes conservative app...

ShareCafeGlobal Biotech Turnaround Looks to Be Underway Signs of life are emerging in the global biotech sector, after the longest and sharpest downturn in history that was so severe it left hundreds US companies trading below cash backing....

The S&P/ASX 200 Index (ASX: XJO) slipped ever so slightly on Thursday after major commodity prices tumbled overnight. The index was 0.01% lower at 6,974.90 points as of the market’s close. The slip came despite a decent performance b...

The ASX 200 finished little changed after failing to sustain a push above 7000. The Australian benchmark hit a seven-week high of 7021 in the first half hour before a session-long fade stripped its gains. The index finished a single poin...

The S&P/ASX 200 traded briefly above 7000 after oil fell to a six-month low and upbeat US economic data soothed global recession worries. The Australian benchmark touched a seven-week high of 7021 before shaving its advance to 12 poi...

The S&P/ASX 200 Index (ASX: XJO) defied its earlier downturn to close higher after the Reserve Bank of Australia (RBA) lifted interest rates for a fourth consecutive month. The index was 0.07% higher at 6,998.10 points at Tuesday’s c...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has fought back and is edging slightly higher. At the time of writing, the benchmark index is up to 6,994.9 points. Four ASX shares that are climbing more than most today are listed...

ShareCafeLunch Report: 2 August, 2022 by Paul Sanger   The Reserve Bank of Australia is expected to hike by 50 basis points after official data showed prices in Australia rose 6.1 per cent in the second quarter compared with a year ago. At...

MELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports on regulatory progress for the Company’s core prostate and kidney cancer imaging programs in the Asia Pacific (A...

Highlights:  WHO has declared Monkeypox a global health emergency as cases have surfaced in 74 countries sofar. In Australia, so far, 44 confirmed cases of Monkeypox have been confirmed. Monkeypox is a disease that causes rash turning...

Highlights:  WHO has declared Monkeypox a global health emergency as cases have surfaced in 74 countries sofar. In Australia, so far, 44 confirmed cases of Monkeypox have been confirmed. Monkeypox is a disease that causes rash turning...